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Lai Kuan Tan,1,2 Xiu Pei Koh,1,2 Chew Chieng Yeo,5 and Kwai Lin Thong1,2
The emergence of Escherichia coli resistant to extended-spectrum cephalosporins (ESCs) is of concern as ESC is
often used to treat infections by Gram-negative bacteria. One-hundred and ten E. coli strains isolated in 2009–
2010 from children warded in a Malaysian tertiary hospital were analyzed for their antibiograms, carriage of
extended-spectrum beta-lactamase (ESBL) and AmpC genes, possible inclusion of the beta-lactamase genes on
an integron platform, and their genetic relatedness. All E. coli strains were sensitive to carbapenems. About 46%
of strains were multidrug resistant (MDR; i.e., resistant to ‡ 3 antibiotic classes) and almost half (45%) were
nonsusceptible to ESCs. Among the MDR strains, high resistance rates were observed for ampicillin (98%),
tetracycline (75%), and trimethoprim/sulfamethoxazole (73%). Out of 110 strains, blaTEM-1 (49.1%), blaCTX-M
(11.8%), and blaCMY-2 (6.4%) were detected. Twenty-one strains were ESBL producers. CTX-M-15 was the pre-
dominant CTX-M variant found and this is the first report of a CTX-M-27-producing E. coli strain from Malaysia.
Majority (3.1%) of the strains harbored class 1 integron-encoded integrases with a predominance of aadA and dfr
genes within the integron variable region. No gene cassette encoding ESBL genes was found and integrons were
not significantly associated with ESBL or non-ESBL producers. Possible clonal expansion was observed for few
CTX-M-15-positive strains but the O25-ST131 E. coli clone known to harbor CTX-M-15 was not detected while
CMY-2-positive strains were genetically diverse.
Introduction
Escherichia coli is part of the common intestinal mi-croflora in mammals and the rapid development of an-
timicrobial resistance in E. coli has been reported
worldwide.42 The most commonly used antibiotics in Ma-
laysia are the cephalosporins for the treatment of infections
according to the National Antibiotic Guidelines of Malay-
sia.23 The emergence of E. coli resistant to extended-spectrum
cephalosporins (ESCs) is of concern since ESC is often used
as first-line antimicrobial agents for infections by Gram-
negative bacteria.42 Resistance to cephalosporins has been
associated with the production of extended-spectrum beta-
lactamase (ESBL) and AmpC enzymes.31 ESBLs are capable
of hydrolyzing penicillins, third-generation cephalosporins,
and monobactams and are inhibited by beta-lactamase in-
hibitors such as clavulanic acid29 whereas AmpC-type beta-
lactamase is responsible for the reduced susceptibility to
ESCs and are poorly inhibited by beta-lactamase inhibitors.42
Currently, CTX-M is the most common ESBL in E. coli with
CTX-M-15 being the most prevalent genotype found in major
parts of the world except for Asia,13 and this has been partly
attributed to the successful spread of the E. coli O25-ST131
clone.14 CMY-2 is the most widespread AmpC gene global-
ly.16 The common resistance mechanisms for ESBLs are due
to the genes that reside on mobile genetic elements
(MGEs).20 The blaTEM or blaSHV gene is often located on
conjugative plasmids; blaGES or blaVEB-1 is found in integrons
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while blaCTX-M can be found in both types of MGE.
4,6,29 In-
tegrons are mobile genetic platforms that are able to acquire
gene cassettes and express them as functional genes includ-
ing the antibiotic resistance phenotypes.5 ESBL-encoding
genes located on integron-like structures facilitate the dis-
semination of such genetic elements and have been reported
worldwide at an increasing rate.4,6
There have been very few reports on the prevalence of
beta-lactamase genes in E. coli isolated from hospitals in
Malaysia19,36 and the Southeast Asian region. Any associa-
tion between ESBL genes and integrons has not been inves-
tigated among Malaysian E. coli strains. Thus, this study was
undertaken to (1) determine the prevalence of different types
of beta-lactamase genes and their respective variants, (2)
determine the level of resistance to ESCs conferred by differ-
ent variants of ESBL and AmpC genes, (3) investigate the
association between integrons and ESBL genes, and (4)
investigate the clonality of ESBL- and AmpC-producing E. coli
strains isolated from children in a Malaysian tertiary hospital.
Materials and Methods
Bacterial strains
One-hundred and ten nonrepeat E. coli strains from stool
samples of children under the age of 5 years were obtained in
2009–2010, from a tertiary hospital in Johor Bahru, a city at the
southern tip of Peninsular Malaysia. These strains were iden-
tified by the clinical microbiology laboratory using standard
cultural methods and biochemical tests. The purity of the
strains was confirmed using eosin methylene blue selective
medium and the strains were stored in cryovials of veal infu-
sion broth with 50% glycerol (Invitrogen) at -20C and -85C.
Antimicrobial susceptibility testing
Antimicrobial susceptibility of E. coli was determined
using the disk diffusion method according to Clinical and
Laboratory Standards Institute (CLSI) guidelines8 on
Mueller-Hinton agar (BD) with commercial disks (Oxoid
Ltd.). The antimicrobial agents used were: ampicillin (AMP,
10 mg), tetracycline (TET, 30 mg), trimethoprim/sulfa-
methoxazole (SXT, 30 mg), nalidixic acid (NAL, 30mg),
streptomycin (STR, 10mg), cefoperazone (CFP, 30mg), kana-
mycin (KAN, 30 mg), chloramphenicol (CHL, 30mg), cef-
triaxone (CRO, 30mg), amoxicillin/clavulanic acid (AMC,
20/10mg), cefotaxime (CTX, 30mg), ciprofloxacin (CIP, 5mg),
aztreonam (ATM, 30mg), cefepime (FEP, 30 mg), gentamicin
(GEN, 10 mg), ceftazidime (CAZ, 30mg), amikacin (AMK,
30 mg), meropenem (MEM, 10 mg), and imipenem (IPM,
10 mg). The minimum inhibitory concentration (MICs) for
CAZ, CTX, CRO, and ATM were determined using E-test
strips (AB Biodisk). E. coli ATCC 25922 and ATCC 35218
were used as control strains.
Phenotypic detection of ESBL
E. coli strains were screened for presumptive ESBL pro-
duction using four antimicrobial disks containing CAZ
(30 mg), CRO (30 mg), CTX (30 mg), and ATM (30mg). Pre-
sumptive-positive ESBL-producing E. coli strains were fur-
ther tested for the ESBL production using the modified
double-disk synergy test (DDST)17 and E-test ESBL strips
(CTX/CTX + clavulanic acid [CT/CTL] and CAZ/CAZ +
clavulanic acid [TZ/TZL]) (AB Biodisk). These two methods
were used to increase the efficiency of ESBL detection.
Strains with positive results for DDST or ESBL E-test were
termed ESBL producers. E. coli ATCC 25922 and ATCC
35218 were used as control strains.8
Detection of genes encoding for beta-lactamase
Polymerase chain reaction (PCR) was used to detect the
presence of seven types of beta-lactamase genes with primers
previously described for the amplification of blaCTX-M
27; bla-
TEM, blaOXA-1, and blaSHV
26; blaVEB
19; blaDHA
28; and blaCMY-2.
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Boiled suspensions of bacterial cells for the 110 strains were
used as DNA templates. For ESC nonsusceptible strains that
did not yield any amplicon for ESBL or AmpC genes, PCR
detection of these beta-lactamase genes was repeated using
genomic DNA prepared using the Wizard Genomic DNA
Purification Kit (Promega). Strains that yielded positive
amplification for blaCTX-M were further subgrouped into
CTX-M groups 1, 2, 8/25, and 9 as described by Ensor et al.11
PCR detection for the CTX-M-15 gene was carried out using
primers described by Conceicao et al.9 Representative am-
plified products were purified and submitted to a commer-
cial facility (First BASE Laboratories) for sequencing to
validate their identities. Strains with the expected amplicon
size for blaCTX-M, blaTEM-1, blaOXA-1, and blaSHV genes that had
been sequenced and validated by sequence alignment were
used as positive controls.
Detection of O25-ST131 clone
Rapid detection of the O25-ST131 E. coli clone was carried
out by PCR as previously described7 for CTX-M-15-producing
strains with inclusion of a positive control validated by DNA
sequencing and alignment analysis.
Detection of class 1, 2, and 3 integrons
All 110 strains were tested for the presence of class 1, class
2, and class 3 integron-encoded integrases using PCR as
described previously.20 Amplification of the gene cassette
regions was carried out for integrase-positive strains (using
the 5¢_CS/3¢_CS primers for gene cassette-bearing class 1
integrons and the attI2-F/orfX-R primers for gene cassettes
in class 2 integrons).20 All PCR amplicons were purified and
submitted to a commercial company for sequencing (First
BASE Laboratories). For strains that shared similar pulsed-
field profiles (PFPs; £ 1 band difference) but with different
integron profiles, PCR detection of integrases and integrons
was repeated using genomic DNA prepared using the Wi-
zard Genomic DNA Purification Kit (Promega).
Pulsed-field gel electrophoresis
Pulsed-field gel electrophoresis (PFGE) for the 110 strains
was performed according to Thong et al.38 with minor
modifications. DNA plugs were digested with 12 U of XbaI
(Promega) and DNA fragments were separated by electro-
phoresis for 25 hr in 0.5 ·TBE buffer at 14C in a CHEF
Mapper system (Bio-Rad) using pulse times of 2.16 to
54.17 sec with XbaI-digested Salmonella enterica serovar
Braenderup H9812 as DNA size marker.38 BioNumerics 6.0
(Applied Maths) was used for data analysis and a dendro-
gram was generated using the Dice coefficient and
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unweighted pair group method using arithmetic averages
(UPGMA) at 1.5% tolerance level.38
Statistical analysis
Statistical analysis was performed with R, version 2.12.2,33
and Fisher’s exact test was used to determine the associa-
tion of integrons and ESBL-producing E. coli strains. A sig-
nificance level of p < 0.05 was considered as statistically
significant.
Results
Antimicrobial resistance rates among the E. coli strains
Eighteen of the 110 (16.4%) E. coli strains were sensitive to
all the 19 antimicrobials tested. The antimicrobial resistance
rates were: AMP (60.0%), TET (42.7%), SXT (34.6%), NAL
(30%), STR (25.5%), CFP (19.1%), KAN (18.2%), CHL (16.4%),
CRO (13.6%), AMC (11.8%), CTX (10.9%), CIP (10.0%), ATM
(6.4%), FEP (4.6%), GEN (2.7%), CAZ (2.7%), and AMK
(0.9%). All the strains were sensitive to carbapenems. About
46% (51/110) of the strains were multidrug resistant (MDR).
Table 1 summarizes the resistance profiles of the 51 MDR.
Among the MDR strains, high resistance rates were observed
for AMP (98%, n= 50/51), TET (75%, n= 38/51), and SXT
(73%, n= 37/51) (Table 1). Three MDR strains had the highest
number of antimicrobial resistance (n = 14) and were resistant
to all broad-spectrum cephalopsorins and monobactam tes-
ted. Fourteen ESC-resistant and nine ESC-intermediate-re-
sistant E. coli strains were also MDR.
Thirty percent (33/110) of the E. coli strains were pre-
sumptive ESBL producers based on initial four-antimicrobial
disk-diffusion screening. Eighteen were ESBL producers
based on DDST. Based on the phenotypic confirmatory test
(ESBL E-test), 15 strains were ESBL producers while 2 were
nondeterminate (Nd) as their MIC values for CTX/CTX +
clavulanic acid and CAZ/CAZ + clavulanic acid were above
the test range. According to the manufacturer’s interpreta-
tion, Nd results might suggest the presence of an inhibitor-
resistant enzyme (such as AmpC enzyme). Thirteen strains
were confirmed as ESBL producers by both phenotypic de-
tection tests (DDST and ESBL E-test methods).
Characterization of beta-lactamase genes
Out of the 7 beta-lactamase genes tested (blaTEM, blaCTX-M,
blaOXA-1, blaSHV, blaVEB, blaDHA, and blaCMY-2) using PCR,
only 3 were detected among the 110 E. coli strains: blaTEM
(49.1%, n= 54), blaCTX-M (11.8%, n = 13), and blaCMY-2 (6.4%,
n = 7). Analysis of the DNA sequence of the blaTEM amplicons
revealed that they belonged to subgroup blaTEM-1 and this
was the most prevalent beta-lactamase gene detected.
All blaCTX-M-positive strains were ESBL producers with
positive results for both DDST and ESBL E-test methods and
the 13 blaCTX-M genes were further subgrouped into CTX-
M-15 (n= 10) and CTX-M-9 (n= 3). Further DNA sequence
analyses of the CTX-M-9 genes revealed two subtypes, CTX-
M-14 (n= 2) and CTX-M-27 (n = 1). No CTX-M subgroup 2 or
8/25 was detected. All strains with blaCMY-2 or blaCTX-M genes
were nonsusceptible to third-generation cephalosporins.
CTX-M enzymes had higher hydrolytic activity against
CTX (MIC, 24–256mg/ml) than CAZ (MIC, 1–16mg/ml).
Majority of the CTX-M-positive E. coli strains (11/13)
showed high resistance levels to CTX with MIC values of
‡ 32 mg/ml. The MIC values for CTX-M-15- and CTX-M-14-
producing E. coli for the four antimicrobial agents were as
follows: CTX (16–256 vs. 24–48 mg/ml), CAZ (2–16 vs. 1–
2mg/ml), CRO (16–256 vs. 48–64mg/ml), and ATM (3–96 vs.
3–8mg/ml).
MIC values of CTX, CAZ, CRO, and ATM for CMY-2-
producing strains were 1.5–3, 3–12, 2–8, and 3–12 mg/ml,
respectively.
Prevalence of O25-ST131 clone
No O25-ST131 clone was present among the 10 CTX-M-15-
positive E. coli strains based on primers described by Cler-
mont et al.7 although the positive control strain gave the
expected band size.
Prevalence of class 1, 2, and 3 integrons
All 110 E. coli strains were screened for class 1, 2, and 3
integron-encoded integrase genes. No class 3 integron-
encoded integrase gene was detected. Among the 110 strains,
48 (43.6%) and 4 strains (3.6%) harbored the intI1 and intI2
integrase genes, respectively. Of the 48 intI1-positive strains,
only 21 yielded amplified products with the 5¢_CS/3¢_CS
primers, implying the presence of gene cassettes, while all 4
intI2 integrase-positive strains harbored gene cassettes as
part of class 2 integrons. Six types of gene cassettes were
identified (Table 2). Three types of aadA genes (aadA1, aadA2,
and aadA5) were identified, which confer resistance to STR
and spectinomycin. The aadB gene (n = 2), which confers re-
sistance to a range of aminoglycosides, namely, GEN, KAN,
and tobramycin, was found to be associated with aadA2 in
the class 1 integrons. Four types of dfr genes (dfrA12, dfrA17,
dfrA5, and dfrA7) were detected in class 1 integrons and one
type (dfrA1) in a class 2 integron. The dfr genes encode for the
enzyme dihydrofolate reductase that mediates resistance to
trimethoprim. The dfrA and aadA genes can exist alone or in
combination with other resistance genes. All E. coli strains
that harbored dfr and aad genes were nonsusceptible to SXT
and aminoglycosides, respectively. The genotypes of the
gene cassettes found in the integrons corresponded to the
resistotypes. Only sat1 gene was identified in class 2 integron
strains, which confers resistance to streptothricin. No beta-
lactamase genes were found within the gene cassettes that
were amplified from the integrase-positive E. coli strains.
Genetic relatedness of the E. coli
strains based on PFGE
PFGE subtyped XbaI-digested genomic DNA of 107
strains into 72 PFPs with a Simpson’s index diversity value
of 0.98, and F-value (coefficient of similarity) ranging from
0.45 to 1.0 (Fig. 1). XbaI digestion of the genomic DNA re-
sulted in a total of 14–26 DNA fragments with sizes ranging
from 20 to 800 kb. Three strains (EC062/10, EC063/10, and
EC075/10) were untypeable although their DNA prepara-
tion was repeated three times. At 85% similarity, a total of 78
strains were clustered into 29 clonal groups, each comprising
of 2–4 strains. Most of the strains within the same clonal
group shared high degree of similarities with closely related
PFPs and similar genotypes. Another 29 strains were less
defined and were not clustered into any clonal group.
E. COLI STRAINS FROM A MALAYSIAN HOSPITAL 3
The 13 CTX-M-positive strains were subtyped into 11
PFPs. Three out of four strains (EC009/09, EC013/09, and
EC019/09) that had the highest detectable MICs for CTX and
CRO (256mg/ml) were grouped together into a clonal group.
These three strains also conferred relatively high resistance to
ATM (MIC, 32–96 mg/ml) and CAZ (8–16mg/ml). All three
strains were highly related with one band difference and
carried both blaCTX-M-15 and class 1 integron (dfrA12-orfF-
aadA2). Seven blaCMY-2-positive strains from different pedi-
atric wards had no apparent linkage as they were found
scattered in the dendrogram.
The PFGE profiles of E. coli in the present study (2009/
2010) were also compared with profiles of previously iso-
lated E. coli (2004) in the same hospital.19 The genetic relat-
edness of the E. coli strains obtained from the same hospital
over a gap of more than 5 years was established from a
dendrogram based on the PFGE profiles (Fig. 2). Overall,
E. coli strains were genetically diverse except for two strains,
EC096/10 (stool sample) and EC33/04 from our earlier
study19 (isolated from tracheal aspirate) that differed by only
a single band (PFGE analysis for these two strains was re-
peated three times).
Prevalence of integrons in ESBL- and non-ESBL-
producing strains
A total of 15 out of the 24 integrons (class 1 + class 2)
detected were found in non-ESBL-producing E. coli and no
significant correlation was found between the ESBL pheno-
type and the carriage of integrons ( p= 0.23).
Discussion
Antimicrobial resistance in E. coli from children’s stool
samples in this study was compared with previous reports
from Malaysia15,19 to observe the trend in antimicrobial re-
sistance keeping in mind that the respective study
Table 1. Antimicrobial Resistance Phenotypes of 51 Multidrug-Resistant Escherichia coli Strains
No. of antimicrobial
resistance Resistance phenotypes
No. of
strains
14 AMP, TET, SXT, NAL, STR, CFP, KAN, CHL, CRO, CTX, CIP, ATM, FEP, CAZ 3
10 AMP, TET, SXT, NAL, STR, CFP, KAN, CHL, AMC, CIP 1
AMP, TET, SXT, STR, CFP, KAN, CRO, CTX, AMC, ATM 1
8 AMP, TET, SXT, NAL, STR, KAN, CHL, CIP 1
AMP, TET, SXT, NAL, STR, CHL, CIP, AMK 1
AMP, TET, SXT, NAL, CFP, KAN, AMC, CIP 1
AMP, TET, SXT, NAL, CFP, CHL, CRO, CTX 1
AMP, TET, SXT, STR, CFP, CHL, CRO, CTX 2
7 AMP, TET, SXT, NAL, STR, KAN, CHL 1
AMP, TET, SXT, NAL, STR, CHL, CIP 2
AMP, TET, SXT, NAL, STR, AMC, CIP 1
AMP, TET, SXT, STR, CFP, KAN, AMC 1
AMP, STR, CFP, KAN, CRO, CTX, FEP 1
6 AMP, TET, SXT, NAL, STR, CIP 1
AMP, TET, SXT, NAL, STR, GEN 2
AMP, CFP, CRO, CTX, ATM, FEP 1
5 AMP, TET, SXT, NAL, STR 1
AMP, TET, SXT, NAL, KAN 4
AMP, TET, SXT, KAN, C 3
AMP, TET, SXT, STR, KAN 1
AMP, TET, SXT, STR, C 1
TET, SXT, STR, KAN, CHL 1
AMP, TET, NAL, CFP, CRO 1
AMP, CFP, CRO, CTX, ATM 1
AMP, SXT, NAL, CFP, CRO 1
AMP, CRO, CTX, AMC, ATM 1
4 AMP, TET, SXT, STR 1
AMP, TET, NAL, CFP 2
AMP, TET, STR, AMC 1
AMP, SXT, NAL, STR 1
AMP, SXT, STR, CHL 1
3 AMP, TET, SXT 1
AMP, TET, AMC 1
AMP, TET, KAN 1
AMP, SXT, STR 1
AMP, SXT, NAL 1
AMP, CFP, AMC 3
AMP, CRO, AMC 1
AMP, ampicillin; TET, tetracycline; SXT, trimethoprim/sulfamethoxazole; NAL, nalidixic acid; STR, streptomycin; CFP, cefoperazone;
KAN, kanamycin; CHL, chloramphenicol; CRO, ceftriaxone; CTX, cefotaxime; CIP, ciprofloxacin; ATM, aztreonam; FEP, cefepime; CAZ,
ceftazidime; AMC, amoxicillin/clavulanic acid; AMK, amikacin; GEN, gentamicin.
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populations were different. All three reports shared similar
findings whereby E. coli strains had low resistance rates to
carbapenems (0%–0.5%) and high resistance rates to AMP
(60%–77%). The resistance rates for ESCs in this study were
generally similar (* – 3%) to those reported in the earlier-
mentioned studies with the exception of FEP and CAZ where
resistance rates were approximately fourfold lower in our
study. The MDR rate was also lower (46%) than those re-
ported by Lim et al.19 (64%) and it should be noted that 23
strains from our previous study19 were from the same hos-
pital, although from an earlier period (i.e., 2004).
Approximately 54% (n= 13/24) of the nonsusceptible ESC
(intermediate and resistant) strains were CTX-M positive.
CTX-M was the most common type of ESBL observed in both
studies (this study: 11.8%; Lim et al.19: 17.0%) with CTX-M-15
as the most common subtype in Malaysia19,36 and India.35
This is in contrast to the report by Hawkey13 that prevalence
of CTX-M-15 is low in Asia. Although CTX-M-14 is the most
prevalent variant of CTX-M in other Asian countries, such as
Korea, China, and Taiwan,37,43,44 it is relatively low in Ma-
laysia with rates of 15.4% (n = 2/13) in this study and 31%
(n = 4/13) in a previous study.36 Perhaps, the prevalence of a
particular genotype is associated with different geographical
regions. To the best of our knowledge, this is the first report
of the presence of a blaCTX-M-27-producing E. coli strain in
Malaysia. The low prevalence of blaCTX-M-27 concurred with
the reports from Korea37 and Canada.32
E. coli strains that carried blaCTX-M genes exhibited higher
resistance to CTX than CAZ (MICs of 8–32-fold dilutions),
consistent with the classical phenotype of CTX-M enzymes.
Nevertheless, a broad range of resistance levels to CTX
(MICs of 24–256 mg/ml) for the E. coli strains that carried the
CTX-M-encoding genes was observed, similar to a previous
report by Edelstein et al.10 This study shows that CTX-M-15
(MIC 2–16mg/ml) has stronger hydrolytic activities against
CAZ compared with its parental enzyme, CTX-M-14 (MIC
1–2 mg/ml). E. coli strains containing CTX-M-27 also ex-
hibited higher resistance levels to CAZ compared with CTX-
M-14 (8 vs. 1–2 mg/ml), which is in agreement with report
from Bonnet et al.3 Although the level of resistance (MIC
value) appeared to be associated with the CTX-M subtype,
however, it should be noted that the MIC value only provi-
des an estimation of the antimicrobial resistance level.
Besides CTX-M-encoding genes, AmpC genes also play
an essential role in conferring nonsusceptibility to broad-
spectrum cephalosporins. In this study, blaCMY-2 was the only
AmpC gene detected in 7 of the 110 E. coli strains. Six out of
seven CMY-2-positive strains were nonsusceptible to ESCs
while another CMY-2-positive strain had reduced suscepti-
bility. All CMY-2-positive strains were resistant to AMC,
a known trait of AmpC-type beta-lactamase (weakly in-
hibited by beta-lactamase inhibitors),2 and consistent with
an AmpC-type beta-lactamase phenotype. The CMY-2-
producing strains also had a higher resistance level (MICs)
to CAZ than for CTX, which is in agreement with the find-
ings of Philippon et al.31 Although the MIC values for
CRO were elevated (3–12mg/ml), it was interpreted as re-
duced susceptibility rather than resistance according to CLSI
guidelines.42 Plasmid-encoded AmpC-type beta-lactamase-
producing strains are often not resistant to third-generation
cephalosporins because they are found in low copy
numbers.12
The remaining five strains that were nonsusceptible to
ESCs did not contain any ESBL or AmpC genes, indicating
that resistance to cephalosporins may be conferred by other
resistance mechanisms.30
The association between ESBL genes and integrons has
been reported worldwide,20,21,40 but no studies have yet been
reported for Malaysian E. coli strains. In this study, class 1
integrons were the most common integrons in the Malaysian
E. coli strains, but no gene cassette encoding ESBL genes was
detected. Sequence analyses of the amplicons revealed a pre-
dominance of gene cassettes that conferred resistance to STR
and spectinomycin (aadA genes) and trimethoprim (dfr genes),
similar to the report of White et al.41 A total of 15 out of 25
integrons (class 1 + class 2) were found in non-ESBL-pro-
ducing E. coli. Integrons were also not significantly found in
either ESBL or non-ESBL producers ( p> 0.05). These findings
infer that integrons are unlikely to have contributed to the
dissemination of the ESBL genes in the Malaysian E. coli
strains. Previous studies by Machado et al.20,21 and Vinue´
et al.40 also indicated that integrons do not contribute much to
the dissemination of ESBL genes unless these genes are lo-
cated within integrons (e.g., CTX-M-9 that linked to In60 in-
tegron). The transmissibility of ESBL genes could be linked to
other mechanisms such as insertion elements and plasmids.34
E. coli strains that contain blaCTX-M genes were genetically
diverse. This observation concurred with other studies25,40
that reported a low clonal relationship among the strains
containing blaCTX-M genes. This indicates that the dispersion
of the E. coli strains with blaCTX-M genes was not likely to be
due to the dissemination of a particular resistant clone har-
boring the gene. However, the three strains that contained
blaCTX-M-15 (EC013/09, EC019/09, and EC009/09) were
highly related. These strains shared similar PFPs and re-
sistotypes and might have been derived from the same clone.
It was also found that EC096/10 from the present study and
EC33/04 from the previous study19 were closely related (one
band difference) (Fig. 2). Similar observations where epide-
miological unrelated E. coli strains had closely related PFGE
patterns have been reported by Mamlouk et al.22 Further
analysis of these strains showed that they were of different
Table 2. Contents of Class 1 and Class 2 Integrons
Gene Cassettes Detected in 23 Integron-Positive
Escherichia coli Strains
Integrons
Gene
cassettes
Amplicon
size (bp)
No. of
strains
Class 1 dfrA12-orfF-aadA2 1,900 8
dfrA17-aadA5 1,600 4
aadB-aadA2 1,600 2
aadA1 1,000 1
dfrA7 800 3
dfrA5 700 1
Class 2 dfrA1-sat1-aadA 2,000 2
Class 1 + Class 2 dfrA12-orfF-aadA2
1,900
2
+
dfrA1-sat1-aadA 2,000
No. of strains
with integrons
23
No. of strains
without integrons
87
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FIG. 1. Dendrogram generated from PFGE profiles of the Escherichia coli strains using UPGMA based on Dice coefficients of
similarity. aStrain code; bbeta-lactamase genes determined by polymerase chain reaction and validated by DNA sequencing;
cintegron-type gene cassettes found in class 1 integrons: (1A) dfrA12-orfF-aadA2; (1B) aadB-aadA2; (1C) dfrA5; (1D) aadA1; (1E)
dfrA7; (1F) dfrA17-aadA5; gene cassette found in class 2 integron: (2A) dfrA1-sat-aadA1; dpulsed-field profiles. The scale on top
of the dendrogram indicates the percentage of similarity. ND, not detected; PFGE, pulsed-field gel electrophoresis; UPGMA,
unweighted pair group method using arithmetic averages.
6
FIG. 2. Dendrogram generated from PFGE profiles of the E. coli strains isolated in years 2004 and 2009/2010 obtained from
the same hospital. Bold letters of strain codes (/04) indicate that the strains were obtained from the previous study (year
2004).19 Strains EC33/04 and EC096/10 isolated 5 years apart showed one band difference.
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resistotypes. No integron was detected in both strains while
blaTEM-1 was detected only in EC33/04. According to van
Belkum et al.,39 strains with indistinguishable typing patterns
do not necessarily belong to the same clone because different
strains may yield indistinguishable patterns using the same
typing method. Nevertheless, the high discriminatory power
of PFGE strongly implies that EC096/10 and EC33/04 are
derived from the same clone. The clonality of these two
strains was further confirmed by rep-PCR24 and plasmid
profiling. Both strains yielded the same rep-PCR profile and
both did not harbor any plasmids (unpublished data). These
results strongly imply that EC096/10 and EC33/04 were
likely from the same clone that had persisted in the hospital
environment with gain or loss of resistance due to the ac-
quisition or deletion of respective genes that are likely to be
located on MGEs.
In summary, the 110 E. coli strains isolated from pediatric
wards of a tertiary hospital in Malaysia showed high resis-
tance rates to AMP and total sensitivity to carbapenems. The
MDR rates were lower compared with other previously re-
ported Malaysian strains. Class 1 integrons remained the
major class of integrons. No gene cassette encoding ESBL
genes was found and no significant association could be
made between ESBL production and the carriage of in-
tegrons. CTX-M-15 was the most common ESBL found in
this study although low prevalence was reported in other
parts of Asia, supporting that the prevalence of genotypes is
associated with different geographical regions. Possible clo-
nal expansion was observed for a few CTX-M-15-positive
strains but no O25-ST131 clone was detected. Further studies
to determine the transferability of MGEs in clinical strains of
E. coli are necessary to further understand the dissemination
of resistance determinants.
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